Bactaegion does not duplicate any scientific data. Everything comes from public databases.
Chargement de l'extrait Wikipédia…
The system that copies human recipes, only simpler.
Viperin bactérienne (bVip) convertit CTP/UTP/GTP en analogues ddh-NTP, terminateurs de chaîne contre l'ARN polymérase virale. Même chimie que Sofosbuvir (anti-VHC Gilead, ~30 Md$ de ventes). Précurseur évolutif naturel d'un blockbuster pharmaceutique majeur.
For two decades, RSAD2 ("Viperin") was a revered mystery among human immunologists: an interferon-induced gene that slows down HIV, HCV, flaviviruses, and even a few coronaviruses, but whose mechanism nobody could pin down. Then Aude Bernheim looked at bacteria. In 2021, her team showed that hundreds of bacteria carry a homolog doing exactly the same thing against phages: producing chain-terminator nucleotides (ddhCTP / ddhGTP). Once identified in the bacterium, the mechanism became obvious in humans — and the bacterial version provided a simpler structural model to crystallize and use as a scaffold for molecule optimization.
ddhCTP is a natural broad-spectrum antiviral. Chemically stabilized (resistant to the phosphatases that normally degrade it within minutes in plasma), it is a credible drug candidate. And the bacterial version remains the best structural template for design.
The name "viperin" was coined in 1995 as an acronym for virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible — five adjectives crammed together. The bacterial version dropped the "endoplasmic reticulum" (bacteria don't have one) but kept everything else. Science is rarely this economical with its vocabulary.
Chargement de l'extrait Wikipédia…
